Queens Cancer Center of Queens Hospital
9
0
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.1%
1 terminated/withdrawn out of 9 trials
85.7%
-0.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Food: A Three-Arm Study Examining Food Insecurity Interventions
Role: collaborator
Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced Cancer
Role: collaborator
Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma
Role: collaborator
Physician Use of Non-English Language Skills in Cancer Care
Role: collaborator
Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases
Role: collaborator
Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver
Role: collaborator
Support Needs and Preferences of Family Caregivers of Lung Cancer Patients
Role: collaborator
Colorectal Cancer Survivors' Needs and Preferences for Survivorship Information
Role: collaborator
Women Surviving Ovarian Cancer
Role: collaborator
All 9 trials loaded